| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
Elevance Health, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$418.14 |
| 52 Week High | US$567.38 |
| 52 Week Low | US$398.67 |
| Beta | 0.85 |
| 11 Month Change | -16.88% |
| 3 Month Change | -22.39% |
| 1 Year Change | -9.56% |
| 33 Year Change | -3.81% |
| 5 Year Change | 47.40% |
| Change since IPO | 61.95% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0HG8 | GB Healthcare | GB Market | |
|---|---|---|---|
| 7D | 0.1% | -2.8% | -0.8% |
| 1Y | -9.6% | -18.2% | 7.9% |
Return vs Industry: 0HG8 exceeded the UK Healthcare industry which returned -18.2% over the past year.
Return vs Market: 0HG8 underperformed the UK Market which returned 7.9% over the past year.
Price Volatility
| 0HG8 volatility | |
|---|---|
| 0HG8 Average Weekly Movement | 4.4% |
| Healthcare Industry Average Movement | 6.4% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.0% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0HG8 has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0HG8's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 104,900 | Gail Boudreaux | www.elevancehealth.com |
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.
Elevance Health, Inc. Fundamentals Summary
| 0HG8 fundamental statistics | |
|---|---|
| Market cap | US$98.66b |
| Earnings (TTM) | US$6.42b |
| Revenue (TTM) | US$174.02b |
14.9x
P/E Ratio0.6x
P/S RatioIs 0HG8 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0HG8 income statement (TTM) | |
|---|---|
| Revenue | US$174.02b |
| Cost of Revenue | US$125.40b |
| Gross Profit | US$48.61b |
| Other Expenses | US$42.20b |
| Earnings | US$6.42b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 27.67 |
| Gross Margin | 27.94% |
| Net Profit Margin | 3.69% |
| Debt/Equity Ratio | 61.9% |
How did 0HG8 perform over the long term?
See historical performance and comparisonDividends
1.6%
Current Dividend Yield23%
Payout RatioDoes 0HG8 pay a reliable dividends?
See 0HG8 dividend history and benchmarks| Elevance Health dividend dates | |
|---|---|
| Ex Dividend Date | Dec 05 2024 |
| Dividend Pay Date | Dec 20 2024 |
| Days until Ex dividend | 22 days |
| Days until Dividend pay date | 37 days |
Does 0HG8 pay a reliable dividends?
See 0HG8 dividend history and benchmarks